813 related articles for article (PubMed ID: 12687033)
1. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
Perri D; Ito S; Rowsell V; Shear NH
Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
[TBL] [Abstract][Full Text] [Related]
2. Renal drug transport: a review.
Bendayan R
Pharmacotherapy; 1996; 16(6):971-85. PubMed ID: 8947968
[TBL] [Abstract][Full Text] [Related]
3. Transporters as a determinant of drug clearance and tissue distribution.
Shitara Y; Horie T; Sugiyama Y
Eur J Pharm Sci; 2006 Apr; 27(5):425-46. PubMed ID: 16488580
[TBL] [Abstract][Full Text] [Related]
4. Human renal organic anion transporters: characteristics and contributions to drug and drug metabolite excretion.
Robertson EE; Rankin GO
Pharmacol Ther; 2006 Mar; 109(3):399-412. PubMed ID: 16169085
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir.
Janneh O; Anwar T; Jungbauer C; Kopp S; Khoo SH; Back DJ; Chiba P
Antivir Ther; 2009; 14(7):965-74. PubMed ID: 19918100
[TBL] [Abstract][Full Text] [Related]
6. Renal nucleoside transporters: physiological and clinical implications.
Elwi AN; Damaraju VL; Baldwin SA; Young JD; Sawyer MB; Cass CE
Biochem Cell Biol; 2006 Dec; 84(6):844-58. PubMed ID: 17215872
[TBL] [Abstract][Full Text] [Related]
7. Effects of renal failure on drug transport and metabolism.
Sun H; Frassetto L; Benet LZ
Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315
[TBL] [Abstract][Full Text] [Related]
8. Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state.
Feng B; LaPerle JL; Chang G; Varma MV
Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):939-52. PubMed ID: 20433402
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic implications of renal anionic drug transporters.
Masereeuw R; Russel FG
Pharmacol Ther; 2010 May; 126(2):200-16. PubMed ID: 20227439
[TBL] [Abstract][Full Text] [Related]
10. Transporters and renal drug elimination.
Lee W; Kim RB
Annu Rev Pharmacol Toxicol; 2004; 44():137-66. PubMed ID: 14744242
[TBL] [Abstract][Full Text] [Related]
11. Drug secretion systems in renal tubular cells: functional models and molecular identity.
Ito S
Pediatr Nephrol; 1999 Nov; 13(9):980-8. PubMed ID: 10603161
[TBL] [Abstract][Full Text] [Related]
12. Membrane transport function in primary cultures of human proximal tubular cells.
Lash LH; Putt DA; Cai H
Toxicology; 2006 Dec; 228(2-3):200-18. PubMed ID: 16997449
[TBL] [Abstract][Full Text] [Related]
13. Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates.
Mandíková J; Volková M; Pávek P; Česnek M; Janeba Z; Kubíček V; Trejtnar F
Toxicology; 2013 Sep; 311(3):135-46. PubMed ID: 23856525
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline.
Nadai M; Kato M; Yoshizumi H; Kimura M; Kurono S; Abe F; Saito H; Hasegawa T
Life Sci; 2007 Sep; 81(15):1175-82. PubMed ID: 17897683
[TBL] [Abstract][Full Text] [Related]
15. Role of P-glycoprotein in the renal transport of dideoxynucleoside analog drugs.
Leung S; Bendayan R
Can J Physiol Pharmacol; 1999 Aug; 77(8):625-30. PubMed ID: 10543726
[TBL] [Abstract][Full Text] [Related]
16. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
[TBL] [Abstract][Full Text] [Related]
17. Drug transporters relevant to HIV therapy.
Thomas SA
J HIV Ther; 2004 Nov; 9(4):92-6. PubMed ID: 15731741
[TBL] [Abstract][Full Text] [Related]
18. Organic anion transporter (Slc22a) family members as mediators of toxicity.
Sweet DH
Toxicol Appl Pharmacol; 2005 May; 204(3):198-215. PubMed ID: 15845414
[TBL] [Abstract][Full Text] [Related]
19. Prediction of the overall renal tubular secretion and hepatic clearance of anionic drugs and a renal drug-drug interaction involving organic anion transporter 3 in humans by in vitro uptake experiments.
Watanabe T; Kusuhara H; Watanabe T; Debori Y; Maeda K; Kondo T; Nakayama H; Horita S; Ogilvie BW; Parkinson A; Hu Z; Sugiyama Y
Drug Metab Dispos; 2011 Jun; 39(6):1031-8. PubMed ID: 21383204
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular aspects of drug transport in the kidney.
Inui KI; Masuda S; Saito H
Kidney Int; 2000 Sep; 58(3):944-58. PubMed ID: 10972658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
